A quarter of a million children in England aged 11 to 17 face a higher risk of developing malignant skin cancer by using ...
NEW YORK (Reuters Health) - People with a history of skin cancer may want to cut back on the amount of fat they ...
FDA panel narrowly backs Schering-Plough's PegIntron as a skin cancer medication Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer. The Food and Drug Administration ...
WASHINGTON (Reuters) - Schering-Plough Corp's injectable drug PegIntron carries "substantial toxicity" and had no effect on overall survival in melanoma skin cancer patients undergoing surgery, U.S. Food and Drug Administration staff reviewers said in documents released on Thursday. Schering is seeking FDA ...
Scientists said on Thursday a new drug had significantly reduced the size of skin cancer tumours in initial tests. A team of US researchers said some melanoma patients in the trial saw a dramatic improvement in their condition and hailed the findings ...
BERLIN (Reuters) - Scientists offered new hope in the fight against the most deadly type of skin cancer on Wednesday as an early-stage clinical trial showed an experimental drug dramatically shrank tumors. Another study also found Roche's established cancer drug Avastin had ...
NEW YORK (Reuters Health) - Very light-skinned children who tan in the sun develop significantly more moles than their peers who stay pale in the sun, new research shows. The number of moles a person has is among the strongest risk factors ...
NEW YORK (Reuters Health) - The good news on teens and indoor tanning: Most U.S. salons seem to be obeying state laws that require parents to consent to their teens' bronzing under the lights, according to a new study. The bad news: ...
BERLIN (Reuters) - Patients with melanoma, a notoriously difficult to treat cancer of the skin, live longer when given Roche's drug Avastin, according to a scientific abstract from Europe's top cancer meeting. The median overall survival in a Phase II trial was ...
NEW YORK (Reuters Health) - Is melanoma, a potentially deadly form of skin cancer, on the rise, as is often reported? Maybe not, says a new study: The "melanoma epidemic" may simply represent a change in how doctors are diagnosing the disease. ...
In order to be considered a common type of cancer, there have to be at least 25,000 new cases diagnosed every year. Even under these strict guidelines, the United States has several types of common cancer. The top danger, preventable by sunscreen ...
CHICAGO (Reuters) - An experimental cancer pill made by Roche's Genentech shrank tumors in patients whose skin cancer had spread, raising hope for a new class of drugs that may have an affect on many other cancers as well, U.S. researchers said ...
